Fundraising FoxDe Novo Ventures — 2010 Investments
1 investments dated 2010 · listed companies and verified rows first · show all
Agile Therapeuticsagiletherapeutics.comin𝕏Series B · Jun 2010 · $45M
Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusion® transdermal technology platform.
BiotechFemTechHealthtechPrinceton, US
Katie MacFarlane(Executive Officer)inScott M. Coiante(Executive Officer)Al Altomari(Executive Officer, Director)inElizabeth Garner(Executive Officer)in
BoardKaren Hong(Director)inAbhijeet Lele(Director)
Co-investorsAisling CapitalKaiser Permanente Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.